Search for the latest oncology news by tumour type
Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led…
In a new study led by Yale Cancer Center, USA, researchers have advanced a tumour-targeting…
Groundbreaking research from Tel Aviv University, Israel, may lead to a significant breakthrough in the…
New research by Yale Cancer Center, USA, shows patients with early-onset colorectal cancer, age 50…
Lower levels of cancer aneuploidy were associated with more favourable outcomes after immune checkpoint inhibition…
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack…
A combination of copanlisib and rituximab led to a 48 percent reduction in the risk…
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Compared with available standard therapies, including immune checkpoint inhibitors, treatment with the bispecific fusion protein…
In cancer, personalised medicine takes advantage of the unique genetic changes in an individual tumour…